Literature DB >> 8169749

L-CAM expression in lymph node and liver metastases of colorectal carcinomas.

A A van der Wurff1, J W Arends, E P van der Linden, J ten Kate, F T Bosman.   

Abstract

L-CAM, also known as E-cadherin, is a cell adhesion molecule expressed on the plasma membranes of epithelial cells at the intercellular interface. From in vitro gene transfection experiments the idea has been conceived that loss of L-CAM expression might be related to the invasive capacity as well as metastatic potential of tumour cells. In several tumours a relation between the grade of differentiation and L-CAM expression has been noticed: loss of differentiation appears to be associated with loss of L-CAM immunoreactivity. Also, in lymph node metastases of poorly differentiated carcinomas loss of L-CAM expression was demonstrated. In this study we describe L-CAM expression in lymphogenous and haematogenous metastases of large bowel adenocarcinomas, using an indirect immunoperoxidase method with the monoclonal anti-L-CAM antibody 6F9. All the metastases studied--lymphogenous as well as haematogenous--demonstrated L-CAM immunoreactivity in a pattern comparable to that of primary tumours. Intratumour heterogeneity in expression was noted, with normal intercellular, apical (non-functional), and focally negative areas in the same tumour. The data indicate that primary tumours and their metastases do not differ strikingly in their pattern of L-CAM expression. This would be consistent with transient rather than constitutive down-regulation of L-CAM in invasive and metastatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8169749     DOI: 10.1002/path.1711720204

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  8 in total

1.  Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.

Authors:  M Ilyas; I P Tomlinson; A Hanby; I C Talbot; W F Bodmer
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

2.  A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.

Authors:  Zongmeng Li; Haiwei Mou; Ting Wang; Jing Xue; Bo Deng; Lihua Qian; Ye Zhou; Wanghua Gong; Ji Ming Wang; Guohao Wu; Cheng-Fu Zhou; Jing Fang; Yingying Le
Journal:  Cancer Lett       Date:  2012-10-08       Impact factor: 8.679

3.  Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines.

Authors:  Y Nakayama; K Okazaki; K Shibao; T Sako; K Hirata; N Nagata; M Kuwano; H Itoh
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

4.  Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers.

Authors:  M Ilyas; M Novelli; K Wilkinson; I P Tomlinson; A M Abbasi; A Forbes; I C Talbot
Journal:  J Clin Pathol       Date:  1997-03       Impact factor: 3.411

5.  Up-regulation of E-cadherin and I-catenin in human hepatocellular carcinoma cell lines by sodium butyrate and interferon-alpha.

Authors:  T Masuda; H Saito; F Kaneko; K Atsukawa; M Morita; H Inagaki; N Kumagai; K Tsuchimoto; A H Ishii
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

6.  Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel.

Authors:  G Gagliardi; O Kandemir; D Liu; M Guida; S Benvestito; T G Ruers; I S Benjamin; J M Northover; G W Stamp; I C Talbot
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  Adhesion or anti-adhesion in cancer: what matters more?

Authors:  S Jothy; S B Munro; L LeDuy; D McClure; O W Blaschuk
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

8.  Prognostic significance of E-cadherin expression in human colorectal cancer tissue.

Authors:  Y Mohri
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.